Pharmaceutical Safety Assessment Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Pharmaceutical Safety Assessment Market Report 2026

Name: Pharmaceutical Safety Assessment Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment), By Drug Type (Biological Drugs, Chemical Drugs), By Phase (Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)), By End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Pharmaceutical Safety Assessment Market Overview

• Pharmaceutical Safety Assessment market size has reached to $11.32 billion in 2025

• Expected to grow to $16.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%

• Growth Driver: Expansion Of Clinical Trials Is Fueling Market Growth Due To Increasing Demand For Drug Safety Assessment

• Market Trend: AI-Driven Platforms Enhancing Accuracy And Efficiency In Toxicity Prediction

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceutical Safety Assessment Market?

Pharmaceutical safety assessment is the systematic evaluation of drugs and pharmaceutical products to ensure their safety and minimize potential risks to patients. It involves analyzing preclinical and clinical data, monitoring adverse effects, and ensuring compliance with regulatory standards. This process helps in making informed decisions regarding the approval, labeling, and safe use of medications.

The main types in the pharmaceutical safety assessment market are in-vitro safety assessment, in-vivo safety assessment, and computational safety assessment. In-vitro safety assessment refers to the evaluation of the safety and toxicity of drugs, chemicals, or other substances using controlled laboratory tests performed outside of a living organism. The various types of drugs include biological drugs and chemical drugs. It spans multiple phases, such as preclinical, clinical (phase I, II, III), and post-market surveillance (phase IV). Key end users include pharmaceutical companies, biotechnology firms, medical device manufacturers, academic and research institutions, and contract research organizations (CROs).

Pharmaceutical Safety Assessment Market Global Report 2026 Market Report bar graph

What Is The Pharmaceutical Safety Assessment Market Size and Share 2026?

The pharmaceutical safety assessment market size has grown strongly in recent years. It will grow from $11.32 billion in 2025 to $12.24 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to expansion of pharmaceutical R&D pipelines, increasing regulatory scrutiny on drug safety, growth in preclinical and clinical testing volumes, wider adoption of in-vitro safety assessment methods, rising use of CRO-led safety studies.

What Is The Pharmaceutical Safety Assessment Market Growth Forecast?

The pharmaceutical safety assessment market size is expected to see strong growth in the next few years. It will grow to $16.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing reliance on computational safety assessment, expansion of personalized medicine development, rising demand for faster regulatory approvals, growing integration of ai in drug safety workflows, increased post-market surveillance requirements. Major trends in the forecast period include increasing use of ai-based toxicity prediction tools, rising adoption of in-silico safety assessment models, growing integration of real-time pharmacovigilance systems, expansion of automated preclinical testing platforms, enhanced focus on regulatory-compliant safety analytics.

Book your 30 minutes free consultation with our research experts

Global Pharmaceutical Safety Assessment Market Segmentation

1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

2) By Drug Type: Biological Drugs, Chemical Drugs

3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

What Is The Driver Of The Pharmaceutical Safety Assessment Market?

The expansion of clinical trials is expected to propel the growth of the pharmaceutical safety assessment market going forward. Clinical trials refer to research studies conducted in humans to evaluate the safety, effectiveness, and side effects of new medical treatments, drugs, or interventions. Clinical trials are rising due to the growing need for new and effective treatments, as researchers and healthcare providers aim to develop therapies that can better prevent, manage, or cure diseases. Clinical trials support pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, determining safe dosage ranges, and providing essential data that regulatory authorities use to ensure that medications are both effective and safe for public use. For instance, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, as of September 26, 2025, a total of 554,798 studies were registered on ClinicalTrials.gov. Therefore, the expansion of clinical trials is driving the growth of the pharmaceutical safety assessment industry.

Key Players In The Global Pharmaceutical Safety Assessment Market

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

Global Pharmaceutical Safety Assessment Market Trends and Insights

Major companies in the pharmaceutical safety assessment market are focusing on developing AI-powered decision support tools to enhance the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is a software system that uses artificial intelligence to analyze data and provide insights that support faster and more accurate decision-making. For instance, in April 2024, Charles River Laboratories, a US-based life sciences company, in partnership with Deciphex, an Ireland-based company enhances diagnostic precision and speed through AI-driven quality assurance, launched the Patholytix Foresight platform, an AI-powered decision support tool, designed to transform toxicologic pathology in pharmaceutical safety assessment. The platform uses artificial intelligence to quickly analyze complex preclinical pathology data, helping identify potential safety risks earlier and reducing subjectivity in results. It offers unique features such as an AI algorithm that detects tissue abnormalities, a cloud-based system for global collaboration, and a scalable design that cuts down slide review time while improving data accuracy and consistency.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Pharmaceutical Safety Assessment Market?

In January 2025, Groupe ProductLife S.A.S., a France-based life sciences services company, acquired Stragen Services SAS for an undisclosed amount. With this acquisition, ProductLife Group aims to enhance its pharmacovigilance and clinical safety capabilities, expand its European market presence, and provide more comprehensive regulatory and safety support to pharmaceutical and biotech clients. Stragen Services SAS is a France-based company that specializes in pharmaceutical safety assessment, also known as pharmacovigilance.

Regional Insights

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Safety Assessment Market?

The pharmaceutical safety assessment market includes revenues earned by entities by providing services such as post-marketing surveillance, safety pharmacology, regulatory consulting and compliance, bioanalytics and biomarker services, and in silico and computational toxicology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Safety Assessment Market Report 2026?

The pharmaceutical safety assessment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical safety assessment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Pharmaceutical Safety Assessment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$12.24 billion
Revenue Forecast In 2035	$16.97 billion
Growth Rate	CAGR of 8.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Drug Type, Phase, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (F
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Safety Assessment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pharmaceutical Safety Assessment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Safety Assessment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pharmaceutical Safety Assessment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Biotechnology, Genomics & Precision Medicine

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Use Of Ai-Based Toxicity Prediction Tools

4.2.2 Rising Adoption Of In-Silico Safety Assessment Models

4.2.3 Growing Integration Of Real-Time Pharmacovigilance Systems

4.2.4 Expansion Of Automated Preclinical Testing Platforms

4.2.5 Enhanced Focus On Regulatory-Compliant Safety Analytics

5. Pharmaceutical Safety Assessment Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Companies

5.3 Medical Device Companies

5.4 Academic And Research Institutions

5.5 Contract Research Organizations (Cros)

6. Pharmaceutical Safety Assessment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Safety Assessment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pharmaceutical Safety Assessment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pharmaceutical Safety Assessment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pharmaceutical Safety Assessment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pharmaceutical Safety Assessment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Safety Assessment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Safety Assessment Market Segmentation

9.1. Global Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment

9.2. Global Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biological Drugs, Chemical Drugs

9.3. Global Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)

9.4. Global Pharmaceutical Safety Assessment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)

9.5. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vitro Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening

9.6. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vivo Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies

9.7. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of Computational Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

10. Pharmaceutical Safety Assessment Market Regional And Country Analysis

10.1. Global Pharmaceutical Safety Assessment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pharmaceutical Safety Assessment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Safety Assessment Market

11.1. Asia-Pacific Pharmaceutical Safety Assessment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Safety Assessment Market

12.1. China Pharmaceutical Safety Assessment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Safety Assessment Market

13.1. India Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Safety Assessment Market

14.1. Japan Pharmaceutical Safety Assessment Market Overview

14.2. Japan Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Safety Assessment Market

15.1. Australia Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Safety Assessment Market

16.1. Indonesia Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Safety Assessment Market

17.1. South Korea Pharmaceutical Safety Assessment Market Overview

17.2. South Korea Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Safety Assessment Market

18.1. Taiwan Pharmaceutical Safety Assessment Market Overview

18.2. Taiwan Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Safety Assessment Market

19.1. South East Asia Pharmaceutical Safety Assessment Market Overview

19.2. South East Asia Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Safety Assessment Market

20.1. Western Europe Pharmaceutical Safety Assessment Market Overview

20.2. Western Europe Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Safety Assessment Market

21.1. UK Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Safety Assessment Market

22.1. Germany Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Safety Assessment Market

23.1. France Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Safety Assessment Market

24.1. Italy Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Safety Assessment Market

25.1. Spain Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Safety Assessment Market

26.1. Eastern Europe Pharmaceutical Safety Assessment Market Overview

26.2. Eastern Europe Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Safety Assessment Market

27.1. Russia Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Safety Assessment Market

28.1. North America Pharmaceutical Safety Assessment Market Overview

28.2. North America Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Safety Assessment Market

29.1. USA Pharmaceutical Safety Assessment Market Overview

29.2. USA Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Safety Assessment Market

30.1. Canada Pharmaceutical Safety Assessment Market Overview

30.2. Canada Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Safety Assessment Market

31.1. South America Pharmaceutical Safety Assessment Market Overview

31.2. South America Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Safety Assessment Market

32.1. Brazil Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Safety Assessment Market

33.1. Middle East Pharmaceutical Safety Assessment Market Overview

33.2. Middle East Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Safety Assessment Market

34.1. Africa Pharmaceutical Safety Assessment Market Overview

34.2. Africa Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Safety Assessment Market Regulatory and Investment Landscape

36. Pharmaceutical Safety Assessment Market Competitive Landscape And Company Profiles

36.1. Pharmaceutical Safety Assessment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pharmaceutical Safety Assessment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pharmaceutical Safety Assessment Market Company Profiles

36.3.1. IQVIA Holding Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. LabCorp (formerly Covance) Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific (PPD) Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Safety Assessment Market Other Major And Innovative Companies

Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc.

38. Global Pharmaceutical Safety Assessment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Safety Assessment Market

40. Pharmaceutical Safety Assessment Market High Potential Countries, Segments and Strategies

40.1 Pharmaceutical Safety Assessment Market In 2030 - Countries Offering Most New Opportunities

40.2 Pharmaceutical Safety Assessment Market In 2030 - Segments Offering Most New Opportunities

40.3 Pharmaceutical Safety Assessment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Pharmaceutical Safety Assessment Market, Overview Of Key Products - Product Examples

Table 2: Global Pharmaceutical Safety Assessment Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Pharmaceutical Safety Assessment Market, Supply Chain Analysis

Table 4: Global Pharmaceutical Safety Assessment Market, Major Raw Material Providers

Table 5: Global Pharmaceutical Safety Assessment Market, Major Resource Providers

Table 6: Global Pharmaceutical Safety Assessment Market, Major Manufacturers (Suppliers)

Table 7: Global Pharmaceutical Safety Assessment Market, Major Distributors And Channel Partners

Table 8: Global Pharmaceutical Safety Assessment Market, Key Technologies & Future Trends

Table 9: Global Pharmaceutical Safety Assessment Market, Major Trends

Table 10: Global Pharmaceutical Safety Assessment Market, Major End Users

Table 11: Global Pharmaceutical Safety Assessment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Pharmaceutical Safety Assessment Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Pharmaceutical Safety Assessment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Pharmaceutical Safety Assessment Market - TAM, US$ Billion, 2025

Table 15: Global Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Pharmaceutical Safety Assessment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vitro Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vivo Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of Computational Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Pharmaceutical Safety Assessment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Pharmaceutical Safety Assessment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Pharmaceutical Safety Assessment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Pharmaceutical Safety Assessment Market - Company Scoring Matrix

Table 98: IQVIA Holding Inc. Financial Performance

Table 99: LabCorp (formerly Covance) Financial Performance

Table 100: Thermo Fisher Scientific (PPD) Financial Performance

Table 101: Charles River Laboratories Financial Performance

Table 102: ICON plc Financial Performance

Table 103: Global Pharmaceutical Safety Assessment Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Pharmaceutical Safety Assessment Market, Competitive Dashboard

Table 105: Global Pharmaceutical Safety Assessment Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Pharmaceutical Safety Assessment Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Pharmaceutical Safety Assessment Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 108: Global, Pharmaceutical Safety Assessment Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030

List Of Figures

Figure 1: Global Pharmaceutical Safety Assessment Market, Overview Of Key Products - Product Examples

Figure 2: Global Pharmaceutical Safety Assessment Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Pharmaceutical Safety Assessment Market, Supply Chain Analysis

Figure 4: Global Pharmaceutical Safety Assessment Market, Major Raw Material Providers

Figure 5: Global Pharmaceutical Safety Assessment Market, Major Resource Providers

Figure 6: Global Pharmaceutical Safety Assessment Market, Major Manufacturers (Suppliers)

Figure 7: Global Pharmaceutical Safety Assessment Market, Major Distributors And Channel Partners

Figure 8: Global Pharmaceutical Safety Assessment Market, Key Technologies & Future Trends

Figure 9: Global Pharmaceutical Safety Assessment Market, Major Trends

Figure 10: Global Pharmaceutical Safety Assessment Market, Major End Users

Figure 11: Global Pharmaceutical Safety Assessment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Pharmaceutical Safety Assessment Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Pharmaceutical Safety Assessment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Pharmaceutical Safety Assessment Market - TAM, US$ Billion, 2025

Figure 15: Global Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Pharmaceutical Safety Assessment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vitro Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vivo Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of Computational Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Pharmaceutical Safety Assessment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Pharmaceutical Safety Assessment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Pharmaceutical Safety Assessment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Pharmaceutical Safety Assessment Market - Company Scoring Matrix

Figure 98: IQVIA Holding Inc. Financial Performance

Figure 99: LabCorp (formerly Covance) Financial Performance

Figure 100: Thermo Fisher Scientific (PPD) Financial Performance

Figure 101: Charles River Laboratories Financial Performance

Figure 102: ICON plc Financial Performance

Figure 103: Global Pharmaceutical Safety Assessment Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Pharmaceutical Safety Assessment Market, Competitive Dashboard

Figure 105: Global Pharmaceutical Safety Assessment Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Pharmaceutical Safety Assessment Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Pharmaceutical Safety Assessment Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 108: Global, Pharmaceutical Safety Assessment Market Size Gain ($ Billion), Segmentation By Phase, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Pharmacovigilance Market Report 2026 - Global Outlook – By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Cont...

Pharmaceutical Label Market Report 2026 - Global Outlook – By Type (Pressure-Sensitive Label, Glue-Applied Label, Sleeve Label, Other Types), By Material (Paper, Polymer Film, Other Materials), By Application (Instructio...

Drug Screening Market Report 2026 - Global Outlook – By Products (Rapid Testing Devices, Consumables, Other Products), By Sample Type (Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types), By ...

Therapeutic Drug Monitoring Market Report 2026 - Global Outlook – By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors), By Class Of Drug (Antiepileptic Drugs, Antibiotic Drugs, Immunos...

Biological Safety Testing Products And Services Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Instruments, Services), By Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication And Ch...

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

Frequently Asked Questions

How big is the Pharmaceutical Safety Assessment Market?

The Pharmaceutical Safety Assessment market was valued at $11.32 billion in 2025, increased to $12.24 billion in 2026, and is projected to reach $16.97 billion by 2030.

What is the Pharmaceutical Safety Assessment market growth?

The global Pharmaceutical Safety Assessment market is expected to grow at a CAGR of 8.5% from 2026 to 2035 to reach $16.97 billion by 2035.

Who are the key players in Pharmaceutical Safety Assessment market?

Some Key Players in the Pharmaceutical Safety Assessment market Include, IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl. .

What is the anticipated growth trend for the Pharmaceutical Safety Assessment market?

Major trend in this market includes: AI-Driven Platforms Enhancing Accuracy And Efficiency In Toxicity Prediction. For further insights on this market. request a sample here

Which region has the most growth potential in the Pharmaceutical Safety Assessment market?

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.